Skip to main content

B vitamins slow brain atrophy in people with memory problems

B vitamins slow brain atrophy in people with memory problems


Image result for vitamins

Daily tablets of certain B vitamins can halve the rate of brain shrinkage in elderly people who suffer from mild memory problems, an Oxford University study has shown.take vitamins today
The two-year randomised clinical trial is the largest to study the effect of B vitamins on mild cognitive impairment, and one of the first disease-modifying trials in the Alzheimer's field to show positive results in people.
Around 1 in 6 elderly people over the age of 70 has mild cognitive impairment, experiencing problems with memory, language, or other mental functions, but not to a degree that interferes with daily life. Around half of people with mild cognitive impairment go on to develop dementia -- mainly Alzheimer's disease -- within five years of diagnosis.
Certain B vitamins -- folic acid, vitamin B6 and vitamin B12 -- are known to control levels of the amino acid homocysteine in the blood, and high levels of homocysteine are associated with an increased risk of Alzheimer's.
So the Oxford team set out to see whether supplements of the B vitamins that lower homocysteine could slow the higher rate of brain shrinkage, or atrophy, observed in mild cognitive impairment or Alzheimer's.
The study followed 168 volunteers aged 70 or over with mild memory problems, half of whom took high dose B vitamin tablets for two years and the other half a placebo tablet. The researchers assessed disease progression in this group by using MRI scans to measure the brain atrophy rate over a two-year period. The findings are published in the journal PLoS ONE.
The team found that on average the brains of those taking the folic acid, vitamin B6 and B12 treatment shrank at a rate of 0.76% a year, while those in the placebo group had a mean brain shrinkage rate of 1.08%. People with the highest levels of homocysteine benefited most, showing atrophy rates on treatment that were half of those on placebo.
Along with rate of brain shrinkage, the team from the Oxford Project to Investigate Memory and Ageing (OPTIMA) also monitored cognitive test scores, revealing that those with the slowest rate of shrinkage scored more strongly.
The team suggests that, since the rate of brain atrophy is known to be more rapid in those with mild cognitive impairment who go on to develop Alzheimer's, it is possible that the vitamin treatment could slow down the development of the disease. Clinical trials to test this should now be carried out, they add.
'It is our hope that this simple and safe treatment will delay the development of Alzheimer's disease in many people who suffer from mild memory problems,' said Professor David Smith of the Department of Pharmacology at Oxford University, a co-leader of the trial. 'Today there are about 1.5 million elderly in UK, 5 million in USA and 14 million in Europe with such memory problems.
'These are immensely promising results but we do need to do more trials to conclude whether these particular B vitamins can slow or prevent development of Alzheimer's. So I wouldn't yet recommend that anyone getting a bit older and beginning to be worried about memory lapses should rush out and buy vitamin B supplements without seeing a doctor,' he said.
Rebecca Wood, Chief Executive of the Alzheimer's Research Trust, which co-funded the study, said: 'These are very important results, with B vitamins now showing a prospect of protecting some people from Alzheimer's in old age. The strong findings must inspire an expanded trial to follow people expected to develop Alzheimer's, and we hope for further success.
'We desperately need to support research into dementia, to help avoid the massive increases of people living with the condition as the population ages. Research is the only answer to what remains the greatest medical challenge of our time.'
Professor Chris Kennard, chair of the Medical Research Council's Neurosciences and Mental Health Board which co-funded the study, said: 'This MRC-funded trial brings us a step closer to unravelling the complex neurobiology of ageing and cognitive decline, which holds the key to the development of future treatments for conditions like Alzheimer's disease. The findings are very encouraging and we look forward to further research that is needed in order to test whether B vitamins can be recommended as a suitable treatment.'take vitamins today
Story Source:
Materials provided by University of Oxford. Note: Content may be edited for style and length.
Journal Reference:
  1. A. David Smith, Stephen M. Smith, Celeste A. de Jager, Philippa Whitbread, Carole Johnston, Grzegorz Agacinski, Abderrahim Oulhaj, Kevin M. Bradley, Robin Jacoby, Helga Refsum, Ashley I. Bush. Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial. PLoS ONE, 2010; 5 (9): e12244 DOI: 10.1371/journal.pone.0012244
Labels:

Comments

Post a Comment

Popular posts from this blog

B-group vitamins can improve concentration among people with first episode psychosis

B-group vitamins can improve concentration among people with first episode psychosis take vitamins today B-group vitamins may be beneficial for maintaining concentration skills among people experiencing a first episode of psychosis, a study by researchers from Orygen, the National Centre of Excellence in Youth Mental Health, has found. take vitamins today The study, led by Dr Colin O'Donnell, now at Letterkenny University Hospital, and Dr Kelly Allott from Orygen, explored the impact of increasing a person's intake of vitamins B12, B6, and folic acid [vitamin B9] after studies in people with schizophrenia revealed that increased intake of these vitamins could decrease patients' levels of an amino acid called homocysteine and improve their symptoms. Dr Allott said elevated levels of homocysteine in people living with schizophrenia had been associated with more severe symptoms. "Given previous studies have shown that increasing the intake of vitamin B12, B6...
Post a Comment
Read more

Master regulator in mitochondria is critical for muscle function and repair

Master regulator in mitochondria is critical for muscle function and repair When we exercise, our muscles can become fatigued, sore and even damaged with very strenuous activities, like running a marathon. Over time our muscles are able to repair themselves through a complex set of cellular processes within each muscle fiber. New research from the MitoCare Center at Thomas Jefferson University, in collaboration with the Center for Genetic Medicine Research at Children's National Health System in Washington D.C., has identified how MICU1, a protein in the mitochondria, the "powerhouses" of all cells, is critical in the maintenance of muscle size and function, and the repair of damaged muscle fibers. The findings point to a potential role of MICU1 in neuromuscular diseases. The study was published in  Cell Reports  on October 29th. The contraction and relaxation of our muscles is dependent on the proper balance of calcium ions inside each muscle fiber. Some of this ...
Post a Comment
Read more

Mitochondria Has A Role In Cellular Copper Regulation

Mitochondria Has A Role In Cellular Copper Regulation Copper is an essential part of our lives. From copper pipes and wires - to important copper-containing proteins in the body, copper is necessary for healthy growth and neurological development. Researchers at the Montreal Neurological Institute at McGill University are studying how copper is processed in our bodies and its distinct role in early development. Their findings, published in a recent edition of the journal Cell Metabolism, identify a new role for two proteins involved with copper regulation. This study may lead to a better understanding of how to treat individuals affected by copper imbalances. "Copper is important in maintaining healthy cells. When copper is not properly regulated in the body it can lead to diseases of the liver, kidneys, brains and eyes," says Dr. Eric Shoubridge, a professor of Human Genetics at the Montreal Neurological Institute, McGill University and lead investigator. "W...
Post a Comment
Read more